Search Results
Pharmaceutical Jurisprudence & Regulation eJournal

70,826 Total downloads | Link to this page | Subscribe to this eJournal (requires login)

Viewing: 1 - 50 of 305 papers

1.

SARS-CoV-2 Transmission Dynamics Should Inform Policy

Number of pages: 16 Posted: 21 Sep 2020
Accepted Paper Series
University of St. Andrews - Division of Infection and Global Health, Harvard Pilgrim Health Care, Harvard University - Center for Communicable Disease Dynamics and Kent State University - College of Public Health
Downloads 12,051
2.

Drugged Out: How Cognitive Bias Hurts Drug Innovation

51 San Diego Law Review 419 (2014)
Number of pages: 90 Posted: 01 Sep 2013 Last Revised: 09 Aug 2014
Accepted Paper Series
Loyola University of Chicago School of Law
Downloads 11,208
3.

Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs

Journal of Law, Medicine and Ethics, 2013, Vol. 14, No. 3: 590-610
Number of pages: 11 Posted: 20 Jun 2013 Last Revised: 11 Apr 2020
Accepted Paper Series
Rowan University School of Osteopathic Medicine, York University and Harvard Medical School
Downloads 7,576
4.

Sharp Reductions in COVID-19 Case Fatalities and Excess Deaths in Peru in Close Time Conjunction, State-By-State, with Ivermectin Treatments

Number of pages: 15 Posted: 21 Jan 2021 Last Revised: 19 May 2021
Working Paper Series
Universidad EAFIT, University of Toronto and US Public Health Service
Downloads 6,714
5.

Correlates and Disparities of COVID-19 Vaccine Hesitancy

Number of pages: 20 Posted: 12 Aug 2020
Working Paper Series
Texas A&M University, The George Washington University, Department of Communication, Baylor College of Medicine, Department of Pediatrics and Molecular Virology & Microbiology, Case Western Reserve University - Department of Economics, Wesleyan University - Government and Oklahoma State University - Stillwater
Downloads 2,522
6.

Drug Regulation in the Philippines

Number of pages: 14 Posted: 24 Apr 2009
Working Paper Series
affiliation not provided to SSRN
Downloads 1,775
7.

Why Neuroscience Matters for a Rational Drug Policy

Minnesota Journal of Law, Science & Technology, 2010
Number of pages: 14 Posted: 10 Apr 2009
Accepted Paper Series
Baylor College of Medicine and affiliation not provided to SSRN
Downloads 1,287
8.

A First Literature Review: Lockdowns Only Had a Small Effect on COVID-19

Number of pages: 21 Posted: 25 Jan 2021 Last Revised: 26 Jan 2021
Working Paper Series
CEPOS
Downloads 1,113
9.

Evidence of Protective Role of Ultraviolet-B (UVB) Radiation in Reducing COVID-19 Deaths

Scientific Reports, 10:17705, October 2020
Number of pages: 55 Posted: 01 May 2020 Last Revised: 03 Nov 2020
Accepted Paper Series
Goethe University Frankfurt, Goethe University Frankfurt and Goethe University Frankfurt
Downloads 1,082
10.

Big Data and Pharmacovigilance: Using Health Information Exchanges to Revolutionize Drug Safety

99 Iowa L. Rev. 225 (2013)
Number of pages: 68 Posted: 08 Apr 2013 Last Revised: 02 May 2015
Accepted Paper Series
University of Surrey School of Law
Downloads 972
11.

Regulation of Pharmaceuticals in Canada

CANADIAN HEALTH LAW AND POLICY, 3rd ed., J. Downie, T. Caulfield & C. Flood, ed., Toronto. Butterworths, pp. 318-387, 2007
Number of pages: 56 Posted: 15 Nov 2012 Last Revised: 06 Apr 2014
Accepted Paper Series
University of Toronto - Faculty of Law and University of Manitoba - Faculty of Law (deceased)
Downloads 934
12.

COVID-19 Futures: A Framework for Exploring Medium and Long-Term Impacts

Number of pages: 15 Posted: 03 Sep 2020
Working Paper Series
Anthrologica, London School of Economics & Political Science (LSE) - Institute of Global Affairs, Harvard University - Center for Communicable Disease Dynamics, Wellcome Trust, Department of Ecology and Evolutionary Biology & the Princeton School of Public & International Affairs, Princeton University, Marie Bashir Institute for Infectious Diseases and Biosecurity, School of Life and Environmental Sciences and School of Medical Sciences, University of Sydney, Department of Ecology and Evolutionary Biology & the Princeton School of Public & International Affairs, Princeton University, University of Edinburgh and Wellcome Trust
Downloads 783
13.

Prescription Drug Policing: The Right to Health Information Privacy Pre- and Post-Carpenter

69 Duke Law Journal 775 (2020)
Number of pages: 79 Posted: 20 Aug 2018 Last Revised: 22 Apr 2020
Accepted Paper Series
Seton Hall University School of Law
Downloads 506
14.

A Prescription for Excessive Drug Pricing: Leveraging Government Patent Use for Health

18 Yale J. L. & Tech. 275 (2016), Yale Law School, Public Law Research Paper No. 577, Yale Law & Economics Research Paper No. 560
Number of pages: 80 Posted: 03 Sep 2016 Last Revised: 21 Sep 2016
Accepted Paper Series
Hagens Berman Sobol Shapiro, Yale University - Law School, Independent and Yale University, Law School, Students
Downloads 499
15.

The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 Pandemic

Research Paper 116, South Centre, Geneva (August 2020), FSU College of Law, Public Law Research Paper No. 930, FSU College of Law, Law, Business & Economics Paper No. 20-16
Number of pages: 40 Posted: 28 Aug 2020
Working Paper Series
Florida State University - College of Law
Downloads 478
16.

Who 'Owns' the Data in a Coronavirus Tracing (And/or Tracking) App?

Coronavirus and the Law in Europe, Examining coronavirus-related legislation and its consequences in European states 2020
Number of pages: 25 Posted: 23 Aug 2020
Working Paper Series
University of Maastricht - Faculty of Law
Downloads 401
17.

Unfavorable Hydroxychloroquine COVID-19 Research Associated with Authors Having a History of Political Party Donations

Number of pages: 25 Posted: 12 Oct 2020
Working Paper Series
Larkin Community Hospital, The Medical College of Wisconsin, Eastern Michigan University, Hillsdale College - Department of Economics and Medical College of Wisconsin
Downloads 386
18.

The U.S. Biologics Price Competition and Innovation Act of 2009 Triggers Public Debates, Regulatory/Policy Risks, and International Trade Concerns

Global Trade and Customs Journal, Vol. 6, No. 11 & 12, 2011
Number of pages: 34 Posted: 03 Nov 2011
Accepted Paper Series
The Kogan Law Group, P.C.
Downloads 383
19.
Downloads 378
20.

College Students' COVID-19 Vaccine Hesitancy

Synnott, C. K. (2021) College Students' COVID-19 Vaccine Hesitancy. The Journal of Higher Education Management, 36(1)
Number of pages: 21 Posted: 23 Dec 2020 Last Revised: 08 Apr 2021
Accepted Paper Series
Eastern Connecticut State University
Downloads 377
21.

The Potential Public Health and Economic Value of a Hypothetical COVID-19 Vaccine in the United States: Use of Cost-Effectiveness Modeling to Inform Vaccination Prioritization

Number of pages: 47 Posted: 25 Sep 2020
Working Paper Series
Quadrant Health Economics Inc, Quadrant Health Economics Inc, Quadrant Health Economics Inc and Harvard University
Downloads 364
22.

A Call to Prosecute Drug Company Fraud As Organized Crime

Number of pages: 51 Posted: 17 Jul 2019
Working Paper Series
James Madison University - Finance and Business Law Program
Downloads 345
23.

Deploying Prescription Drug Monitoring to Address the Overdose Crisis: Ideology Meets Reality

Indiana Health Law Review, Vol. 15, No. 2, pp. 139 - 187 (2018), Northeastern University School of Law Research Paper No. 323-2018
Number of pages: 49 Posted: 09 May 2018 Last Revised: 29 May 2018
Accepted Paper Series
Northeastern University - School of Law; Northeastern University - Bouvé College of Health Sciences
Downloads 345
24.

The Mensing Conundrum: Litigating Generic Drug Injuries in California

California Business Practice (September 2013)
Number of pages: 12 Posted: 10 Apr 2013 Last Revised: 20 Sep 2014
Accepted Paper Series
University of San Diego- School of Business Administration, University of San Diego - School of Business Administration and University of San Diego - School of Business
Downloads 345
25.

Facilitating Access to Cross-Border Supplies of Patented Pharmaceuticals: The Case of the COVID-19 Pandemic

Journal of International Economic Law (Oxford), Volume 23, Issue 3, pp. 535-561, Sept. 2020, FSU College of Law, Law, Business & Economics Paper No. 20-14, Duke Law School Public Law & Legal Theory Series No. 2020-46, FSU College of Law, Public Law Research Paper No. 927
Number of pages: 27 Posted: 25 Jul 2020 Last Revised: 17 Nov 2020
Working Paper Series
Florida State University - College of Law and Duke University School of Law
Downloads 308
26.

Ethical Payment to Participants in Human Infection Challenge Studies, with a Focus on SARS-CoV-2: Report and Recommendations

Number of pages: 116 Posted: 16 Aug 2020
Working Paper Series
Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, University of Pennsylvania - Perelman School of Medicine, Independent, Bank of America, Faculty of Law & Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, University of Sheffield, Dept. of Economics, Stanford University, University of Arkansas for Medical Sciences - College of Medicine and Independent
Downloads 306
27.

Dosing Discrimination: Regulating PDMP Risk Scores

110 California Law Review __ (forthcoming 2022)
Number of pages: 65 Posted: 19 Jan 2021 Last Revised: 23 Mar 2021
Accepted Paper Series
Seton Hall University School of Law
Downloads 298
28.

Pharmaceutical Antitrust: What the Trump Administration Can Do

Concurrences: Competition Law Review 63 (No. 4, 2016)
Number of pages: 3 Posted: 05 Dec 2016
Accepted Paper Series
Rutgers Law School
Downloads 298
29.

The Food and Drug Administration's Evolving Regulation of Press Releases: Limits and Challenges

Food and Drug Law Journal, Vol. 61, p. 623, 2006
Number of pages: 31 Posted: 25 Apr 2007
Accepted Paper Series
Arnold & Porter, Southern Methodist University - Dedman School of Law and Pharmaceutical Research and Manufacturers of America (PhRMA)
Downloads 295
30.

Allocation of COVID-19 Vaccines Under Limited Supply

Number of pages: 37 Posted: 31 Aug 2020 Last Revised: 28 Sep 2020
Working Paper Series
University of Illinois at Urbana-Champaign, University of Illinois at Urbana-Champaign, Massachusetts Institute of Technology (MIT) - School of Engineering and University of Illinois at Urbana-Champaign
Downloads 289
31.

An Unnecessary Proposal: A WTO Waiver of Intellectual Property Rights for COVID-19 Vaccines

Cato Institute, Free Trade Bulletin No.78 (2020)
Number of pages: 5 Posted: 02 Feb 2021
Accepted Paper Series
University of Central Florida
Downloads 274
32.

Exit Route? The Case for Variolation Against COVID-19

Number of pages: 29 Posted: 25 Jun 2020
Working Paper Series
Independent
Downloads 266
33.

Allocating Medicine Fairly in an Unfair Pandemic

2021 University of Illinois Law Review 1085 (2021), U Denver Legal Studies Research Paper No. 20-26
Number of pages: 52 Posted: 28 Sep 2020 Last Revised: 15 Jun 2021
Accepted Paper Series
University of Denver Sturm College of Law
Downloads 264
34.

New Business Models for Sustainable Antibiotics

Centre on Global health Security Working Group Papers, Chatham House (The Royal Institute of International Affairs), Working Groups on Antimicrobial Resistance, Paper 1, February, 2014 , Boston Univ. School of Law, Public Law Research Paper No. 14-10, Boston Univ. School of Law, Law and Economics Research Paper No. 14-10
Number of pages: 34 Posted: 20 Feb 2014
Accepted Paper Series
Boston University School of Law
Downloads 263
35.

Manufacturing and Regulatory Barriers to Generic Drug Competition: A Structural Model Approach

Number of pages: 43 Posted: 24 Mar 2018 Last Revised: 30 Apr 2020
Working Paper Series
University of Illinois at Urbana-Champaign - Department of Business Administration, University of Michigan, Stephen M. Ross School of Business and University of Michigan, Stephen M. Ross School of Business
Downloads 255
36.

Evidence and Extrapolation: Mechanisms for Regulating Off-Label Uses of Drugs and Devices

Duke Law Journal, Vol. 64, No. 3, 2014, Yale Law & Economics Research Paper # 492
Number of pages: 59 Posted: 22 Feb 2014 Last Revised: 02 May 2015
Accepted Paper Series
University of Surrey School of Law and Yale University - Yale Law School
Downloads 237
37.

Synergic Viral-Bacterial Co-Infection in Catalase-Deficient COVID-19 Patients Causes Suppressed Innate Immunity and Lung Damages Due to Detrimental Elevation of Hydrogen Peroxide Concentration

Number of pages: 26 Posted: 17 Jul 2020 Last Revised: 15 Sep 2020
Working Paper Series
University of Hamburg - Center for Hybrid Nanostructures and University of Hamburg - Hamburg Center for Health Economics
Downloads 229
38.

Approval and Withdrawal of New Antibiotics and Other Antiinfectives in the U.S., 1980-2009

Journal of Law, Medicine and Ethics, p. 688, Fall 2013, Boston Univ. School of Law, Law and Economics Research Paper No. 13-47
Number of pages: 10 Posted: 18 Sep 2013 Last Revised: 08 Aug 2015
Accepted Paper Series
Boston University School of Law, George Washington University, Director International Center for Pharmaceutical Economics and Policy, University of Massachusetts and Brigham and Women's Hospital/Harvard Medical School
Downloads 212
39.

The Ethics of Postmarketing Observational Studies of Drug Safety Under Section 505(o)(3) of the Food, Drug, and Cosmetic Act

38 American Journal of Law and Medicine 577-606 (2012), U of Houston Law Center No. 2012-A-19
Number of pages: 30 Posted: 15 Mar 2012 Last Revised: 02 Jul 2014
Accepted Paper Series
University of Florida Levin College of Law
Downloads 199
40.

Regulation of Health Related Nano Applications in India: Exploring the Limitations of the Current Regulatory Design

Number of pages: 25 Posted: 18 Mar 2008 Last Revised: 01 Jul 2008
Working Paper Series
Resources and Global Security Division, The Energy and Resources Institute (TERI) and University of Twente - School of Management and Governance
Downloads 198
41.

Expanding Access to Patents for COVID-19

Burris, S., de Guia, S., Gable, L., Levin, D.E., Parmet, W.E., Terry, N.P. (Eds.) (2020). Assessing Legal Responses to COVID-19. Boston: Public Health Law Watch, University of Utah College of Law Research Paper No. 390
Number of pages: 5 Posted: 03 Sep 2020 Last Revised: 03 Sep 2020
Accepted Paper Series
University of Utah - S.J. Quinney College of Law
Downloads 197
42.

Independent Drug Testing to Ensure Drug Safety and Efficacy

Journal of Health Care Law & Policy, Vol. 18, p. 43, 2015, Edmond J. Safra Working Papers, No. 23, Suffolk University Law School Research Paper No. 14-44
Number of pages: 40 Posted: 19 Sep 2013 Last Revised: 10 Jan 2015
Accepted Paper Series
Suffolk University Law School
Downloads 197
43.

The Role of General Risk Preferences in Messaging About COVID-19 Vaccine Take-Up

Number of pages: 23 Posted: 03 Aug 2020
Working Paper Series
Vanderbilt University, University of Chicago - Booth School of Business and Stanford University - Department of Psychology
Downloads 193
44.

The Effect of State Marijuana Legalizations: 2021 Update

Cato Institute, Policy Analysis No. 908
Number of pages: 40 Posted: 19 Mar 2021
Accepted Paper Series
Western Carolina University, Cato Institute, Cato Institute and Cato Institute
Downloads 190
45.

23andMe, the Food and Drug Administration, and the Future of Genetic Testing

174 JAMA Internal Medicine E1-E2 (2014), Stanford Public Law Working Paper No. 2402877
Number of pages: 2 Posted: 01 Mar 2014
Accepted Paper Series
Ohio State University (OSU) - Michael E. Moritz College of Law, University of Illinois College of Law and Stanford Law School
Downloads 185
46.

Federal Regulatory Responses to the Prescription Opioid Crisis: Too Little, Too Late?

2019 Utah L. Rev. 757
Number of pages: 43 Posted: 26 Feb 2019 Last Revised: 23 Oct 2020
Accepted Paper Series
University of Florida Levin College of Law
Downloads 185
47.

Competition and Risk

Number of pages: 72 Posted: 03 Apr 2020 Last Revised: 28 Jan 2021
Working Paper Series
Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital and Harvard Medical School
Downloads 182
48.

Tell Me How It Ends: The Path to Nationalizing the U.S. Pharmaceutical Industry

University of Michigan Journal of Law Reform, Forthcoming, Indiana University Robert H. McKinney School of Law Research Paper No. 2019-10
Number of pages: 73 Posted: 18 Dec 2019 Last Revised: 02 Apr 2020
Accepted Paper Series
Indiana University Robert H. McKinney School of Law
Downloads 181
49.
Downloads 179
50.

Innovation Policy and the Market for Vaccines

Journal of Law and the Biosciences (Forthcoming), Stanford Law and Economics Olin Working Paper No. 549
Number of pages: 49 Posted: 08 May 2020 Last Revised: 15 May 2020
Accepted Paper Series
Stanford University - Department of Economics and Stanford Law School
Downloads 176